HRT Financial’s Dr. Reddy's Laboratories RDY Stock Holding History

HRT Financial’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.09M	Buy	+144,259	New	+$1.95M	﹤0.01%	1723
2026 Q1	–	Sell	-65,214	Closed	-$915K	–	4567
2025 Q4	$915K	Sell	65,214 -128,707	-66%	-$1.81M	﹤0.01%	1776
2025 Q3	$2.71M	Buy	+193,921	New	+$2.79M	0.01%	983
2025 Q2	–	Sell	-167,506	Closed	-$2.21M	–	3385
2025 Q1	$2.21M	Buy	167,506 +62,591	+60%	+$864K	0.01%	771
2024 Q4	$1.66M	Buy	104,915 +87,895	+516%	+$1.32M	0.01%	822
2024 Q3	$270K	Buy	17,020 +1,760	+12%	+$28.3K	﹤0.01%	1842
2024 Q2	$232K	Buy	+15,260	New	+$219K	﹤0.01%	1598
2019 Q3	–	Sell	-36,770	Closed	-$275K	–	1570
2019 Q2	$275K	Buy	+36,770	New	+$289K	0.02%	565

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

HRT Financial's RDY Position: Q2 2026 in Review

HRT Financial opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 144,259 shares worth $2.09M. The stake represents ﹤0.01% of the portfolio and ranks #1723 among its holdings. This is a return to the name: HRT Financial previously reported a position in RDY as recently as Q4 2025.

HRT Financial first reported a position in RDY in Q2 2019 and has held it in 8 quarters since. The position peaked at $2.71M in Q3 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

HRT Financial held 144,259 shares of Dr. Reddy's Laboratories worth $2.09M as of Q2 2026.
Dr. Reddy's Laboratories was a new HRT Financial position in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #1723 holding.
HRT Financial first reported a position in Dr. Reddy's Laboratories in Q2 2019 and has held it in 8 quarters since.
HRT Financial's Dr. Reddy's Laboratories position peaked at $2.71M in Q3 2025.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.